We are delighted to announce Amanda Cashen, MD has accepted the positon of IRB Executive Chair for Washington University. Amanda previously served as the Interim IRB Executive Chair following Dr. Jonathan Green’s departure this past October.
Dr. Cashen, Associate Professor of Medicine in the Division of Oncology, Section of Stem Cell Transplant/Leukemia, has extensive experience in the conduct of clinical trials of novel therapies for leukemias and lymphomas, collaborates with translational researchers as the principal investigator of the Lymphoid Malignancies Banking Protocol, and has enrolled hundreds of patients in clinical trials over the past 20 years. She earned a B.S. in Molecular Biophysics and Biochemistry from Yale University, M.D. from Washington University, and completed her training in Internal Medicine and Hematology/Medical Oncology at Washington University/Barnes-Jewish Hospital. Amanda’s clinical practice focuses on the care of patients with hematologic malignancies, including stem cell transplant and cellular immunotherapies.
Amanda has served as a Washington University IRB committee member for over ten years, a chair of the IRB protocol review committee since 2007, and as a member of the Protocol Adherence Review Committee (PARC) for the past four years. As Washington University’s IRB Executive Chair, Amanda will hold leadership responsibility for IRB review and approval of human subject research in accordance with current guidelines, institutional policies, and federal and state regulations governing human subject protections.
Amanda’s extraordinary clinical research career, broad knowledge in the conduct of IRB meetings, criteria for protocol review and approval and the regulations for human subject’s research makes her an excellent choice for this position. Amanda will be serving an approximate four year renewable term starting on May 1, 2019.
Please join us in congratulating Amanda in her new role.
Jennifer K. Lodge, PhD
Vice Chancellor for Research
Michael Kass, MD
Senior Associate Dean for Human Research Protection